Clinical Trial Update: Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing telavancin to vancomycin for hospital-acquired pneumonia due to MRSA has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia
• Methicillin-resistant Staphylococcus Aureus Infection

Drugs mentioned

• Telavancin (telavancin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Bacterial Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2010-02-01